Tamar Securities LLC Purchases 12,800 Shares of SPDR S&P Biotech ETF $XBI

Tamar Securities LLC increased its position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 24.2% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 65,763 shares of the exchange traded fund’s stock after acquiring an additional 12,800 shares during the period. Tamar Securities LLC’s holdings in SPDR S&P Biotech ETF were worth $8,018,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also bought and sold shares of the company. China Universal Asset Management Co. Ltd. lifted its holdings in SPDR S&P Biotech ETF by 868.3% during the 3rd quarter. China Universal Asset Management Co. Ltd. now owns 4,919 shares of the exchange traded fund’s stock worth $493,000 after buying an additional 4,411 shares during the period. Banque Pictet & Cie SA lifted its holdings in SPDR S&P Biotech ETF by 24.1% during the 4th quarter. Banque Pictet & Cie SA now owns 64,877 shares of the exchange traded fund’s stock worth $7,910,000 after buying an additional 12,595 shares during the period. Apella Capital LLC acquired a new position in SPDR S&P Biotech ETF during the 4th quarter worth about $490,000. PNC Financial Services Group Inc. lifted its holdings in SPDR S&P Biotech ETF by 60.9% during the 3rd quarter. PNC Financial Services Group Inc. now owns 70,527 shares of the exchange traded fund’s stock worth $7,067,000 after buying an additional 26,705 shares during the period. Finally, Mirae Asset Global Investments Co. Ltd. lifted its holdings in SPDR S&P Biotech ETF by 106.9% during the 4th quarter. Mirae Asset Global Investments Co. Ltd. now owns 26,570 shares of the exchange traded fund’s stock worth $3,240,000 after buying an additional 13,729 shares during the period.

SPDR S&P Biotech ETF Stock Performance

Shares of XBI opened at $133.79 on Monday. The company has a market capitalization of $8.54 billion, a PE ratio of 11.47 and a beta of 0.85. SPDR S&P Biotech ETF has a 12 month low of $80.90 and a 12 month high of $139.19. The stock’s 50-day moving average price is $132.63 and its two-hundred day moving average price is $127.18.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.